Back to HHLR ADVISORS, LTD. HHLR ADVISORS, LTD.

CTNMCTNM
Showing 8 of 9 quarters

Position history for HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.'s holdings in CONTINEUM THERAPEUTICS INC

Yes. HHLR Advisors holds 669,337 shares of CTNM (Contineum Therapeutics), worth $11M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. HHLR Advisors has held CTNM in every 13F on record since Q2 2024, 9 quarterly filings. CTNM is 1.3% of HHLR Advisors' reported 13F portfolio.

Current Value

$11M

Current Shares

669,337

Total Value Change

-$1.8M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
669,337
0.0%
$11M1.3%$16.39
0
2026-Q1
Unchanged
669,337
0.0%
$8.7M0.5%$14.10
0
2025-Q4
Unchanged
669,337
0.0%
$7.7M0.2%$11.40
0
2025-Q3
Unchanged
669,337
0.0%
$7.9M0.2%$11.82
0
2025-Q2
Unchanged
669,337
0.0%
$2.7M0.1%$4.11
0
2025-Q1
Unchanged
669,337
0.0%
$4.7M0.1%$7.07
0
2024-Q4
Unchanged
669,337
0.0%
$9.8M0.3%$14.47
0
2024-Q3
Unchanged
669,337
0.0%
$12.8M0.3%$18.84
0

Other major holders of CTNM: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used